Last month, the Office of Health Economics published a report titled “Health Technology Assessment of Gene Therapies: Are Our Methods Fit for Purpose?” I summarize some of the key challenges and solutions below. Challenge #1: Initial assessment of clinical effectiveness. Since gene therapies often target rare disease, the sample size from clinical trials is often...<p class="more-link-wrap"><a href="https://www.kickosacademy.com/challenge-in-hta-for-gene-therapies/" class="more-link">Read More<span class="screen-reader-text"> “Challenge in HTA for gene therapies”</span> »</a></p>
Moderna and Pfizer have been working on new Covid-19 vaccines designed to offer better protection against the Omicron variants than the original mRNA vaccines have. * This article was originally published here
Last month, CMS announced its final decision regarding expansion of reimbursement eligibility for annual lung cancer screening with low dose computed tomography. CMS is lowering the eligible age for smokers from 55 to 50, and reducing pack-year smoking history from 30 to 20 pack-years. * This article was originally published here
COVID-19 vaccines have had a huge beneficial impact on patient health. One study found that between December 2020 and June 2021, COVID-19 vaccines saved 240,000 lives (Vilches et al. 2022). The figure below shows that as the Delta and Omicron variants spread in the fall of 2021, COVID-19 vaccines prevented significant number of deaths according...<p class="more-link-wrap"><a href="https://www.kickosacademy.com/is-making-mrna-vaccines-for-infectious-diseases-profitable/" class="more-link">Read More<span class="screen-reader-text"> “Is making mRNA vaccines for infectious diseases profitable?”</span> »</a></p>
Moderna Aims To Make Vaccines Against 15 Deadly Diseases—And The Next Pandemic
The company’s new public health initiative aims to work with middle- and low-income countries to combat diseases, while working with scientists worldwide to develop vaccines for the next potentially deadly outbreak.